Page last updated: 2024-09-03

pd 117302 and nalorphine

pd 117302 has been researched along with nalorphine in 1 studies

Compound Research Comparison

Studies
(pd 117302)
Trials
(pd 117302)
Recent Studies (post-2010)
(pd 117302)
Studies
(nalorphine)
Trials
(nalorphine)
Recent Studies (post-2010) (nalorphine)
48021,134416

Protein Interaction Comparison

ProteinTaxonomypd 117302 (IC50)nalorphine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.1095
Delta-type opioid receptorRattus norvegicus (Norway rat)0.004
Kappa-type opioid receptorMus musculus (house mouse)0.1095
Mu-type opioid receptorRattus norvegicus (Norway rat)0.004
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.004
Mu-type opioid receptorMus musculus (house mouse)0.1095
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holtzman, SG; Powell, KR1

Other Studies

1 other study(ies) available for pd 117302 and nalorphine

ArticleYear
Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
    European journal of pharmacology, 1999, Jul-14, Volume: 377, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Benzofurans; Benzomorphans; Conditioning, Operant; Dose-Response Relationship, Drug; Ethylketocyclazocine; Nalorphine; Naltrexone; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Reinforcement Schedule; Saimiri; Thiophenes

1999